NCT06697080

Brief Summary

A total of 50 patients with androgenetic alopecia were selected for the study. Patients who met the inclusion/exclusion criteria were randomly assigned to groups A and B in a 1:1 ratio to receive treatment, with the enrollment date designated as Day 1. Group A visited the clinic once each in the first, second, and third months for treatment with exosomes, while Group B visited the clinic twice each in the first, second, and third months for treatment with exosomes. At the time points of 1, 2, 3, and 6 months after the start of the treatment period, dermatoscopic examinations were conducted on patients in both groups. The differences in hair growth density, hair shaft thickness, and follicle counts within a 1 cm diameter area were compared between the two groups. Additionally, the data differences for each subject at baseline and at the end of the experiment were also assessed.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 28, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 28, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 20, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2024

Completed
Last Updated

November 20, 2024

Status Verified

November 1, 2024

Enrollment Period

3 months

First QC Date

November 17, 2024

Last Update Submit

November 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • hair diameters changed over time

    hair diameters changed over time

    0 days, 1 month, 3 months, 6 months

Study Arms (2)

Group A

EXPERIMENTAL

Group A visited the clinic once each in the first, second, and third months for treatment with exosomes

Drug: Human umbilical cord mesenchymal stem cells

Group B

EXPERIMENTAL

Group B visited the clinic twice each in the first, second, and third months for treatment with exosomes.

Drug: Human umbilical cord mesenchymal stem cells

Interventions

Human umbilical cord mesenchymal stem cells

Group AGroup B

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Plastic and Aesthetic Surgery, Nanfang Hospital Southern 8 Medical University

Guangzhou, Guangdong, China

Location

MeSH Terms

Conditions

Alopecia

Condition Hierarchy (Ancestors)

HypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2024

First Posted

November 20, 2024

Study Start

June 28, 2024

Primary Completion

September 28, 2024

Study Completion

December 28, 2024

Last Updated

November 20, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations